Home Top Movers What Caused Amneal Pharmaceuticals (AMRX) To Rise 4% After-Hours On Friday? –...

What Caused Amneal Pharmaceuticals (AMRX) To Rise 4% After-Hours On Friday? – Here Is An Explanation

Shares of fully integrated pharmaceutical company Amneal Pharmaceuticals Inc (AMRX) raised +3.9% on Friday after ring of the bell. The new came on the heels of news about the company receiving an Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA).

Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

What actually happened?


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The Bridgewater, NJ.-based AMRX manufactures, distributes, and develops generic and specialty pharmaceutical products. It works together to deliver high-quality medicines to patients primarily within the United States and also through activities in Asia, the European Union, and North America. Amneal has an extensive portfolio of 250 or more product families, and it continues expanding its product universe to cover a broad range of therapeutic areas, including biosimilars, in a variety of dosage forms. Also within the Company’s Specialty segment focused primarily on central nervous system and endocrine disorders, the Specialty segment markets a portfolio of branded pharmaceuticals as well.

Read More

Amneal on Friday announced that it had received FDA approval for a hybrid transdermal treatment containing 150mcg/day Norelgestromin and 35mcg/day Ethinyl Estradiol.

  • Amneal has been awarded 180 days of exclusivity by the FDA concurrent with its approval as a Competitive Generic Therapy (CGT).
  • There is a generic version of the reference listed drug (RLD) Ortho Evra in Amneal’s Norelgestromin and Ethinyl Estradiol Transdermal System.
  • The product will be marketed as a 12.5 cm2 patch with a proprietary name called Zafemy.
  • The product will be recommended to Women whose BMI is 30 kg/m2 or below and who are advised to use a combined hormonal contraceptive to avoid pregnancy.
  • Females weighing more than 198 pounds (90 kg) may have less success preventing pregnancy with Zafemy.
  • The company expects to start commercializing the product on March 1, 2021.

    Get the hottest stocks to trade every day before the market opens 100% free. Click here now. 

Finally,

A leading healthcare data and analytics provider, IQVIA, calculates that the U.S. sales for all Xulane products were $332 million in the twelve months ended December 2020. Mylan’s Xulane is currently the only option available on the market, but Zafemy is the most complete alternative for the same which indicates growth opportunity for the newly launched product at an impressively high rate.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

F5 Networks Inc. (FFIV) stock soars during pre-market trading. Here’s to know why?

F5 Networks Inc. (FFIV) stock gained by 0.23% at the last close while the FFIV stock surged by 6.05% in the pre-market trading session....

Here is why Cerecor Inc. (CERC) stock turnaround in the after-hours on Monday?

Cerecor Inc. (CERC) shares gained 12.23% in after-hours on Monday, July 26, 2021, and closed the trading at $3.12. in the regular trading session,...

Here is why Bit Digital Inc. (BTBT) stock skyrocketed on Monday?

Bit Digital Inc. (BTBT) shares declined 10.94% in after-hours on Monday, July 26, 2021, and closed the day at $7.90. Earlier in the regular...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam